Divya Grover

Latest articles

1d
Channel NewsAsia
FDA teams with medical companies in Puerto Rico to tackle shortagestaking steps to mitigate shortages by importing devices from outside the United
Channel NewsAsia / Posted yesterday
taking steps to mitigate shortages by importing devices from outside the United States or allowing manufacturers to shift production to alternative sites, the FDA said. (Reporting by Divya Grover in Bengaluru; Editing by Anil D'Silva)Source: Reu... Read more
2d
Reuters
Imprimis Pharma to take on Allergan's Restasis with cheaper productAllergan said. Shares of Imprimis, which had a market cap of $29.3 million at
Reuters / Posted 2 days ago
Allergan said. Shares of Imprimis, which had a market cap of $29.3 million at the close of trade on Wednesday, closed up 28.8 percent at $1.88. Reporting by Manas Mishra and Divya Grover in Bengaluru; Editing by Bernard Orr and Shounak... Read more
2d
Channel NewsAsia
Imprimis Pharma to take on Allergan's Restasis with cheaper productof Imprimis, which had a market cap of US$29.3 million at the close of trade on
Channel NewsAsia / Posted 2 days ago
of Imprimis, which had a market cap of US$29.3 million at the close of trade on Wednesday, closed up 28.77 percent at US$1.88. (Reporting by Manas Mishra and Divya Grover in Bengaluru; Editing by Bernard Orr and Shounak Dasgupta)Source... Read more
4d
Channel NewsAsia
Alnyalm, Vir partner on RNAi-based drugs for infectious diseasesmonth, Alnyalm said its RNAi-based drug succeeded a key study to treat a rare g
Channel NewsAsia / Posted 4 days ago
month, Alnyalm said its RNAi-based drug succeeded a key study to treat a rare genetic disease, validating the new treatment and bringing it closer to the market. (Reporting by Divya Grover in Bengaluru; Editing by Anil D'Silva)Sour... Read more
4d
EuroNews
Regeneron-Sanofi drug succeeds mid-stage studywhile Sanofi was slightly up before the bell on Monday. (The story cor
EuroNews / Posted 4 days ago
while Sanofi was slightly up before the bell on Monday. (The story corrects infection to inflammation in first paragraph and removes reference to food allergy in headline) (Reporting by Divya Grover in Bengaluru; Editing by Martina D’C... Read more
6d
Channel NewsAsia
Regeneron-Sanofi throat infection drug succeeds key studydupilumab, was statistically significant in improving the ability to swallow in
Channel NewsAsia / Posted 6 days ago
dupilumab, was statistically significant in improving the ability to swallow in adults with moderate to severe eosinophilic esophagitis, when compared with a placebo. (Reporting by Divya Grover in Bengaluru; Editing by Martina D'Couto)Source: Reut... Read more
8d
Newsmax
18 States Sue to Block Trump Obamacare Subsidies CutHurley, Justin Mitchell, Steve Holland, Makini Brice, Jeff Mason and Susan Heav
Newsmax / Posted 8 days ago
Hurley, Justin Mitchell, Steve Holland, Makini Brice, Jeff Mason and Susan Heavey in Washington, Megan Davies in New York, Brendan O'Brien in Milwaukee, and Divya Grover in Bengaluru; Writing by Will Dunham; Editing by Lisa Von Ahn and Leslie A... Read more
2052 related articles
8d
Reuters
U.S. states sue to block Trump Obamacare subsidies cutHurley, Justin Mitchell, Steve Holland, Makini Brice, Jeff Mason and Susan Heav
Reuters / Posted 8 days ago
Hurley, Justin Mitchell, Steve Holland, Makini Brice, Jeff Mason and Susan Heavey in Washington, Megan Davies in New York, Brendan O'Brien in Milwaukee, and Divya Grover in Bengaluru; Writing by Will Dunham; Editing by Lisa Von Ahn and Leslie... Read more
2052 related articles
8d
Channel NewsAsia
US states plan suit to block Trump Obamacare subsidies cutMitchell, Steve Holland, Makini Brice, Jeff Mason and Susan Heavey in Washingto
Channel NewsAsia / Posted 8 days ago
Mitchell, Steve Holland, Makini Brice, Jeff Mason and Susan Heavey in Washington, Megan Davies in New York, Brendan O'Brien in Milwaukee, and Divya Grover in Bengaluru; Writing by Will Dunham; Editing by Lisa Von Ahn and Leslie Adler)Source: Re... Read more
2052 related articles
8d
Reuters
U.S. states plan suit to block Trump Obamacare subsidies cutby Jeff Mason, Steve Holland, Makini Brice, Lawrence Hurley and Susan Heavey in
Reuters / Posted 8 days ago
by Jeff Mason, Steve Holland, Makini Brice, Lawrence Hurley and Susan Heavey in Washington, Megan Davies in New York, Brendan O'Brien in in Milwaukee and Divya Grover in Bengaluru; Writing by Will Dunham; Editing by Bernadette Baum and Lisa V... Read more
2052 related articles
8d
Reuters
Trump ends key insurance subsidies, vows to dismantle Obamacarereporting by Steve Holland, Makini Brice, Lawrence Hurley and Susan Heavey in W
Reuters / Posted 8 days ago
reporting by Steve Holland, Makini Brice, Lawrence Hurley and Susan Heavey in Washington, Megan Davies in New York, Brendan O'Brien in in Milwaukee and Divya Grover in Bengaluru; Writing by Will Dunham; Editing by Bernadette Baum and Lisa... Read more
2052 related articles
11d
Reuters
Pharmacy benefit manager Express Scripts to buy eviCore for $3.6 blnFlom LLP. J.P. Morgan Securities LLC and Morgan Stanley & Co LLC advised eviCo
Reuters / Posted 11 days ago
Flom LLP. J.P. Morgan Securities LLC and Morgan Stanley & Co LLC advised eviCore and Paul, Weiss, Rifkind, Wharton & Garrison LLP is its legal adviser. Reporting by Manas Mishra and Divya Grover in Bengaluru; Editing by Savio D'Souza and Bernard... Read more
12d
Reuters
Pharmacy benefit manager Express Scripts to buy eviCore for $3.6 billionFlom LLP. J.P. Morgan Securities LLC and Morgan Stanley & Co LLC advised eviCo
Reuters / Posted 12 days ago
Flom LLP. J.P. Morgan Securities LLC and Morgan Stanley & Co LLC advised eviCore and Paul, Weiss, Rifkind, Wharton & Garrison LLP is its legal adviser. Reporting by Manas Mishra and Divya Grover in Bengaluru; Editing by Savio D'Souza and Bernard... Read more
6 related articles
15d
Channel NewsAsia
Flexion's knee pain drug gets FDA nodepidemic a national emergency. Osteoarthritis knee pain is a degenerative join
Channel NewsAsia / Posted 15 days ago
epidemic a national emergency. Osteoarthritis knee pain is a degenerative joint disease that affected more than 14 million Americans in 2015. (Reporting by Divya Grover and Tamara Mathias in Bengaluru; Editing by Martina D'Couto)Source:... Read more
18d
Reuters
Mylan surges, Teva slumps after FDA okays Copaxone copyletter said the company might be eligible for 180 days exclusivity on the drug.
Reuters / Posted 18 days ago
letter said the company might be eligible for 180 days exclusivity on the drug. Mylan spokeswoman Julie Knell declined to comment beyond the release at this time. Reporting by Divya Grover in Bengaluru; Editing by Savio D'Souza and Patrick... Read more
2 related articles
18d
Reuters
Mylan surges as its generic of Teva's Copaxone gets FDA nodit would introduce a slew of measures to speed up bringing to market generic ve
Reuters / Posted 18 days ago
it would introduce a slew of measures to speed up bringing to market generic versions of complex drugs in an attempt to address the rising cost of pharmaceuticals in the United States. Reporting by Divya Grover in Bengaluru; Editing by Savio D'S... Read more
2 related articles
19d
Channel NewsAsia
RedHill Biopharma's bowel syndrome drug succeeds in mid-stage studywith diarrhea met the main goal in a mid-stage study. The drug, Bekinda, showe
Channel NewsAsia / Posted 19 days ago
with diarrhea met the main goal in a mid-stage study. The drug, Bekinda, showed improvement in stool consistency response in patients, when compared with a placebo. (Reporting by Divya Grover in Bengaluru; Editing by Bernard Orr)Source:... Read more
26d
Channel NewsAsia
Axovant's Alzheimer's drug fails late-stage trialwith mild to moderate Alzheimer's who did not respond to initial therapy, and w
Channel NewsAsia / Posted 26 days ago
with mild to moderate Alzheimer's who did not respond to initial therapy, and was compared with a placebo. Shares of the company were halted in premarket trading on Tuesday. (Reporting by Divya Grover; Editing by Sriraj Kalluvila)Source:... Read more
27d
Channel NewsAsia
FDA declines to approve Intellipharma's opioid painkillerof the drug when used via oral and nasal methods, the company said. A panel of
Channel NewsAsia / Posted 27 days ago
of the drug when used via oral and nasal methods, the company said. A panel of independent advisers to the FDA had voted 22-1 against approving the drug in July. (Reporting by Divya Grover in Bengaluru; Editing by Sriraj Kalluvila)Source: R... Read more

In this news